The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cell Therapy CMO Market Research Report 2025

Global Cell Therapy CMO Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1728447

No of Pages : 107

Ask Your Query
Synopsis
Highlights
The global Cell Therapy CMO market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Cell Therapy CMO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Cell Therapy CMO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Cell Therapy CMO in Commercial is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Cell Therapy CMO include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO and Cell Therapies, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Stem Cell, which accounted for % of the global market of Cell Therapy CMO in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell Therapy CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy CMO.
The Cell Therapy CMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cell Therapy CMO market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy CMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Product Type Insights
Global markets are presented by Cell Therapy CMO type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Cell Therapy CMO are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Cell Therapy CMO segment by Type
Stem Cell
Non-Stem Cell
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Cell Therapy CMO market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Cell Therapy CMO market.
Cell Therapy CMO Segment by Application
Commercial
Academic Research
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cell Therapy CMO market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy CMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Cell Therapy CMO and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Cell Therapy CMO industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy CMO.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CMO Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy CMO Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy CMO Market Perspective (2017-2028)
2.2 Cell Therapy CMO Growth Trends by Region
2.2.1 Cell Therapy CMO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Therapy CMO Historic Market Size by Region (2017-2022)
2.2.3 Cell Therapy CMO Forecasted Market Size by Region (2023-2028)
2.3 Cell Therapy CMO Market Dynamics
2.3.1 Cell Therapy CMO Industry Trends
2.3.2 Cell Therapy CMO Market Drivers
2.3.3 Cell Therapy CMO Market Challenges
2.3.4 Cell Therapy CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy CMO Players by Revenue
3.1.1 Global Top Cell Therapy CMO Players by Revenue (2017-2022)
3.1.2 Global Cell Therapy CMO Revenue Market Share by Players (2017-2022)
3.2 Global Cell Therapy CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy CMO Revenue
3.4 Global Cell Therapy CMO Market Concentration Ratio
3.4.1 Global Cell Therapy CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CMO Revenue in 2021
3.5 Cell Therapy CMO Key Players Head office and Area Served
3.6 Key Players Cell Therapy CMO Product Solution and Service
3.7 Date of Enter into Cell Therapy CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy CMO Breakdown Data by Type
4.1 Global Cell Therapy CMO Historic Market Size by Type (2017-2022)
4.2 Global Cell Therapy CMO Forecasted Market Size by Type (2023-2028)
5 Cell Therapy CMO Breakdown Data by Application
5.1 Global Cell Therapy CMO Historic Market Size by Application (2017-2022)
5.2 Global Cell Therapy CMO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Therapy CMO Market Size (2017-2028)
6.2 North America Cell Therapy CMO Market Size by Country (2017-2022)
6.3 North America Cell Therapy CMO Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell Therapy CMO Market Size (2017-2028)
7.2 Europe Cell Therapy CMO Market Size by Country (2017-2022)
7.3 Europe Cell Therapy CMO Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy CMO Market Size (2017-2028)
8.2 Asia-Pacific Cell Therapy CMO Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell Therapy CMO Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell Therapy CMO Market Size (2017-2028)
9.2 Latin America Cell Therapy CMO Market Size by Country (2017-2022)
9.3 Latin America Cell Therapy CMO Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy CMO Market Size (2017-2028)
10.2 Middle East & Africa Cell Therapy CMO Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell Therapy CMO Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Therapy CMO Introduction
11.1.4 Charles River Revenue in Cell Therapy CMO Business (2017-2022)
11.1.5 Charles River Recent Development
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Detail
11.2.2 The Discovery Labs Business Overview
11.2.3 The Discovery Labs Cell Therapy CMO Introduction
11.2.4 The Discovery Labs Revenue in Cell Therapy CMO Business (2017-2022)
11.2.5 The Discovery Labs Recent Development
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Detail
11.3.2 BIOCENTRIQ Business Overview
11.3.3 BIOCENTRIQ Cell Therapy CMO Introduction
11.3.4 BIOCENTRIQ Revenue in Cell Therapy CMO Business (2017-2022)
11.3.5 BIOCENTRIQ Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2017-2022)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Exothera
11.5.1 Exothera Company Detail
11.5.2 Exothera Business Overview
11.5.3 Exothera Cell Therapy CMO Introduction
11.5.4 Exothera Revenue in Cell Therapy CMO Business (2017-2022)
11.5.5 Exothera Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell Therapy CMO Introduction
11.6.4 WuXi AppTec Revenue in Cell Therapy CMO Business (2017-2022)
11.6.5 WuXi AppTec Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Detail
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Cell Therapy CMO Introduction
11.7.4 Pharmaron Revenue in Cell Therapy CMO Business (2017-2022)
11.7.5 Pharmaron Recent Development
11.8 OBiO
11.8.1 OBiO Company Detail
11.8.2 OBiO Business Overview
11.8.3 OBiO Cell Therapy CMO Introduction
11.8.4 OBiO Revenue in Cell Therapy CMO Business (2017-2022)
11.8.5 OBiO Recent Development
11.9 Cell Therapies
11.9.1 Cell Therapies Company Detail
11.9.2 Cell Therapies Business Overview
11.9.3 Cell Therapies Cell Therapy CMO Introduction
11.9.4 Cell Therapies Revenue in Cell Therapy CMO Business (2017-2022)
11.9.5 Cell Therapies Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Detail
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Cell Therapy CMO Introduction
11.10.4 AGC Biologics Revenue in Cell Therapy CMO Business (2017-2022)
11.10.5 AGC Biologics Recent Development
11.11 Cytiva
11.11.1 Cytiva Company Detail
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Cell Therapy CMO Introduction
11.11.4 Cytiva Revenue in Cell Therapy CMO Business (2017-2022)
11.11.5 Cytiva Recent Development
11.12 Helixmith
11.12.1 Helixmith Company Detail
11.12.2 Helixmith Business Overview
11.12.3 Helixmith Cell Therapy CMO Introduction
11.12.4 Helixmith Revenue in Cell Therapy CMO Business (2017-2022)
11.12.5 Helixmith Recent Development
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Detail
11.13.2 ThermoGenesis Business Overview
11.13.3 ThermoGenesis Cell Therapy CMO Introduction
11.13.4 ThermoGenesis Revenue in Cell Therapy CMO Business (2017-2022)
11.13.5 ThermoGenesis Recent Development
11.14 Anemocyte
11.14.1 Anemocyte Company Detail
11.14.2 Anemocyte Business Overview
11.14.3 Anemocyte Cell Therapy CMO Introduction
11.14.4 Anemocyte Revenue in Cell Therapy CMO Business (2017-2022)
11.14.5 Anemocyte Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Cell Therapy CMO Introduction
11.15.4 Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2017-2022)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 CBM
11.16.1 CBM Company Detail
11.16.2 CBM Business Overview
11.16.3 CBM Cell Therapy CMO Introduction
11.16.4 CBM Revenue in Cell Therapy CMO Business (2017-2022)
11.16.5 CBM Recent Development
11.17 Bio Elpida
11.17.1 Bio Elpida Company Detail
11.17.2 Bio Elpida Business Overview
11.17.3 Bio Elpida Cell Therapy CMO Introduction
11.17.4 Bio Elpida Revenue in Cell Therapy CMO Business (2017-2022)
11.17.5 Bio Elpida Recent Development
11.18 Genezen
11.18.1 Genezen Company Detail
11.18.2 Genezen Business Overview
11.18.3 Genezen Cell Therapy CMO Introduction
11.18.4 Genezen Revenue in Cell Therapy CMO Business (2017-2022)
11.18.5 Genezen Recent Development
11.19 CCRM
11.19.1 CCRM Company Detail
11.19.2 CCRM Business Overview
11.19.3 CCRM Cell Therapy CMO Introduction
11.19.4 CCRM Revenue in Cell Therapy CMO Business (2017-2022)
11.19.5 CCRM Recent Development
11.20 RoslinCT
11.20.1 RoslinCT Company Detail
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy CMO Introduction
11.20.4 RoslinCT Revenue in Cell Therapy CMO Business (2017-2022)
11.20.5 RoslinCT Recent Development
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Detail
11.21.2 GenScript ProBio Business Overview
11.21.3 GenScript ProBio Cell Therapy CMO Introduction
11.21.4 GenScript ProBio Revenue in Cell Therapy CMO Business (2017-2022)
11.21.5 GenScript ProBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Cell Therapy CMO Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Stem Cell
Table 3. Key Players of Non-Stem Cell
Table 4. Global Cell Therapy CMO Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cell Therapy CMO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cell Therapy CMO Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cell Therapy CMO Market Share by Region (2017-2022)
Table 8. Global Cell Therapy CMO Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cell Therapy CMO Market Share by Region (2023-2028)
Table 10. Cell Therapy CMO Market Trends
Table 11. Cell Therapy CMO Market Drivers
Table 12. Cell Therapy CMO Market Challenges
Table 13. Cell Therapy CMO Market Restraints
Table 14. Global Cell Therapy CMO Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cell Therapy CMO Market Share by Players (2017-2022)
Table 16. Global Top Cell Therapy CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2021)
Table 17. Ranking of Global Top Cell Therapy CMO Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cell Therapy CMO Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy CMO Product Solution and Service
Table 21. Date of Enter into Cell Therapy CMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy CMO Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cell Therapy CMO Revenue Market Share by Type (2017-2022)
Table 25. Global Cell Therapy CMO Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cell Therapy CMO Revenue Market Share by Type (2023-2028)
Table 27. Global Cell Therapy CMO Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cell Therapy CMO Revenue Market Share by Application (2017-2022)
Table 29. Global Cell Therapy CMO Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cell Therapy CMO Revenue Market Share by Application (2023-2028)
Table 31. North America Cell Therapy CMO Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Cell Therapy CMO Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Cell Therapy CMO Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Cell Therapy CMO Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Cell Therapy CMO Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Cell Therapy CMO Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Cell Therapy CMO Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Cell Therapy CMO Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Cell Therapy CMO Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Cell Therapy CMO Market Size by Country (2023-2028) & (US$ Million)
Table 41. Charles River Company Detail
Table 42. Charles River Business Overview
Table 43. Charles River Cell Therapy CMO Product
Table 44. Charles River Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 45. Charles River Recent Development
Table 46. The Discovery Labs Company Detail
Table 47. The Discovery Labs Business Overview
Table 48. The Discovery Labs Cell Therapy CMO Product
Table 49. The Discovery Labs Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 50. The Discovery Labs Recent Development
Table 51. BIOCENTRIQ Company Detail
Table 52. BIOCENTRIQ Business Overview
Table 53. BIOCENTRIQ Cell Therapy CMO Product
Table 54. BIOCENTRIQ Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 55. BIOCENTRIQ Recent Development
Table 56. FUJIFILM Diosynth Biotechnologies Company Detail
Table 57. FUJIFILM Diosynth Biotechnologies Business Overview
Table 58. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product
Table 59. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 60. FUJIFILM Diosynth Biotechnologies Recent Development
Table 61. Exothera Company Detail
Table 62. Exothera Business Overview
Table 63. Exothera Cell Therapy CMO Product
Table 64. Exothera Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 65. Exothera Recent Development
Table 66. WuXi AppTec Company Detail
Table 67. WuXi AppTec Business Overview
Table 68. WuXi AppTec Cell Therapy CMO Product
Table 69. WuXi AppTec Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 70. WuXi AppTec Recent Development
Table 71. Pharmaron Company Detail
Table 72. Pharmaron Business Overview
Table 73. Pharmaron Cell Therapy CMO Product
Table 74. Pharmaron Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 75. Pharmaron Recent Development
Table 76. OBiO Company Detail
Table 77. OBiO Business Overview
Table 78. OBiO Cell Therapy CMO Product
Table 79. OBiO Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 80. OBiO Recent Development
Table 81. Cell Therapies Company Detail
Table 82. Cell Therapies Business Overview
Table 83. Cell Therapies Cell Therapy CMO Product
Table 84. Cell Therapies Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 85. Cell Therapies Recent Development
Table 86. AGC Biologics Company Detail
Table 87. AGC Biologics Business Overview
Table 88. AGC Biologics Cell Therapy CMO Product
Table 89. AGC Biologics Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 90. AGC Biologics Recent Development
Table 91. Cytiva Company Detail
Table 92. Cytiva Business Overview
Table 93. Cytiva Cell Therapy CMOProduct
Table 94. Cytiva Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 95. Cytiva Recent Development
Table 96. Helixmith Company Detail
Table 97. Helixmith Business Overview
Table 98. Helixmith Cell Therapy CMOProduct
Table 99. Helixmith Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 100. Helixmith Recent Development
Table 101. ThermoGenesis Company Detail
Table 102. ThermoGenesis Business Overview
Table 103. ThermoGenesis Cell Therapy CMOProduct
Table 104. ThermoGenesis Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 105. ThermoGenesis Recent Development
Table 106. Anemocyte Company Detail
Table 107. Anemocyte Business Overview
Table 108. Anemocyte Cell Therapy CMOProduct
Table 109. Anemocyte Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 110. Anemocyte Recent Development
Table 111. Thermo Fisher Scientific Company Detail
Table 112. Thermo Fisher Scientific Business Overview
Table 113. Thermo Fisher Scientific Cell Therapy CMOProduct
Table 114. Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 115. Thermo Fisher Scientific Recent Development
Table 116. CBM Company Detail
Table 117. CBM Business Overview
Table 118. CBM Cell Therapy CMOProduct
Table 119. CBM Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 120. CBM Recent Development
Table 121. Bio Elpida Company Detail
Table 122. Bio Elpida Business Overview
Table 123. Bio Elpida Cell Therapy CMOProduct
Table 124. Bio Elpida Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 125. Bio Elpida Recent Development
Table 126. Genezen Company Detail
Table 127. Genezen Business Overview
Table 128. Genezen Cell Therapy CMOProduct
Table 129. Genezen Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 130. Genezen Recent Development
Table 131. CCRM Company Detail
Table 132. CCRM Business Overview
Table 133. CCRM Cell Therapy CMOProduct
Table 134. CCRM Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 135. CCRM Recent Development
Table 136. RoslinCT Company Detail
Table 137. RoslinCT Business Overview
Table 138. RoslinCT Cell Therapy CMOProduct
Table 139. RoslinCT Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 140. RoslinCT Recent Development
Table 141. GenScript ProBio Company Detail
Table 142. GenScript ProBio Business Overview
Table 143. GenScript ProBio Cell Therapy CMOProduct
Table 144. GenScript ProBio Revenue in Cell Therapy CMO Business (2017-2022) & (US$ Million)
Table 145. GenScript ProBio Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy CMO Market Share by Type: 2021 VS 2028
Figure 2. Stem Cell Features
Figure 3. Non-Stem Cell Features
Figure 4. Global Cell Therapy CMO Market Share by Application in 2021 & 2028
Figure 5. Commercial Case Studies
Figure 6. Academic Research Case Studies
Figure 7. Others Case Studies
Figure 8. Cell Therapy CMO Report Years Considered
Figure 9. Global Cell Therapy CMO Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Cell Therapy CMO Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Cell Therapy CMO Market Share by Region: 2021 VS 2028
Figure 12. Global Cell Therapy CMO Market Share by Players in 2021
Figure 13. Global Top Cell Therapy CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Cell Therapy CMO Revenue in 2021
Figure 15. North America Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Cell Therapy CMO Market Share by Country (2017-2028)
Figure 17. United States Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Cell Therapy CMO Market Share by Country (2017-2028)
Figure 21. Germany Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Cell Therapy CMO Market Share by Region (2017-2028)
Figure 29. China Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Cell Therapy CMO Market Share by Country (2017-2028)
Figure 37. Mexico Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Cell Therapy CMO Market Share by Country (2017-2028)
Figure 41. Turkey Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Cell Therapy CMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Charles River Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 44. The Discovery Labs Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 45. BIOCENTRIQ Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 46. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 47. Exothera Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 48. WuXi AppTec Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 49. Pharmaron Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 50. OBiO Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 51. Cell Therapies Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 52. AGC Biologics Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 53. Cytiva Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 54. Helixmith Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 55. ThermoGenesis Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 56. Anemocyte Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 58. CBM Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 59. Bio Elpida Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 60. Genezen Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 61. CCRM Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 62. RoslinCT Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 63. GenScript ProBio Revenue Growth Rate in Cell Therapy CMO Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock